These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 12845662)
1. Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by cisplatin and 5-fluorouracil. Iwase M; Watanabe H; Kondo G; Ohashi M; Nagumo M Int J Cancer; 2003 Sep; 106(4):619-625. PubMed ID: 12845662 [TBL] [Abstract][Full Text] [Related]
2. Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95-mediated apoptosis by down-regulating FLIP-L expression. Kinoshita H; Yoshikawa H; Shiiki K; Hamada Y; Nakajima Y; Tasaka K Int J Cancer; 2000 Dec; 88(6):986-91. PubMed ID: 11093825 [TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor inhibitors enhance susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells. Iwase M; Takaoka S; Uchida M; Yoshiba S; Kondo G; Watanabe H; Ohashi M; Nagumo M Oral Oncol; 2008 Apr; 44(4):361-8. PubMed ID: 17689285 [TBL] [Abstract][Full Text] [Related]
4. Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis. Hyer ML; Sudarshan S; Kim Y; Reed JC; Dong JY; Schwartz DA; Norris JS Cancer Biol Ther; 2002; 1(4):401-6. PubMed ID: 12432255 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of susceptibility to Fas-mediated apoptosis in oral squamous cell carcinoma cells by phosphatidylinositol 3-kinase inhibitor. Kondo G; Iwase M; Watanabe H; Uchida M; Takaoka S; Ohashi M; Nagumo M Oral Oncol; 2006 Aug; 42(7):745-52. PubMed ID: 16527514 [TBL] [Abstract][Full Text] [Related]
6. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. Micheau O; Solary E; Hammann A; Dimanche-Boitrel MT J Biol Chem; 1999 Mar; 274(12):7987-92. PubMed ID: 10075697 [TBL] [Abstract][Full Text] [Related]
7. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Fulda S; Meyer E; Debatin KM Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein. Frese S; Brunner T; Gugger M; Uduehi A; Schmid RA J Thorac Cardiovasc Surg; 2002 Jan; 123(1):168-74. PubMed ID: 11782771 [TBL] [Abstract][Full Text] [Related]
9. Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells. Haag C; Stadel D; Zhou S; Bachem MG; Möller P; Debatin KM; Fulda S Gut; 2011 Feb; 60(2):225-37. PubMed ID: 20876774 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines. Okamura M; Shimada J; Sakagami H Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853 [TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637 [TBL] [Abstract][Full Text] [Related]
12. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis. Kim JH; Ajaz M; Lokshin A; Lee YJ Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965 [TBL] [Abstract][Full Text] [Related]
13. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signalling. Kamarajan P; Sun NK; Chao CC Biochem J; 2003 Nov; 376(Pt 1):253-60. PubMed ID: 12911332 [TBL] [Abstract][Full Text] [Related]
15. Resistance to Fas-mediated apoptosis in malignant tumours is rescued by KN-93 and cisplatin via downregulation of c-FLIP expression and phosphorylation. Yang BF; Xiao C; Li H; Yang SJ Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1245-51. PubMed ID: 17973862 [TBL] [Abstract][Full Text] [Related]
16. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes. Bergmann-Leitner ES; Abrams SI Cancer Immunol Immunother; 2001 Nov; 50(9):445-55. PubMed ID: 11761438 [TBL] [Abstract][Full Text] [Related]
17. Involvement of caspases in 5-FU induced apoptosis in an oral cancer cell line. Ohtani T; Hatori M; Ito H; Takizawa K; Kamijo R; Nagumo M Anticancer Res; 2000; 20(5A):3117-21. PubMed ID: 11062731 [TBL] [Abstract][Full Text] [Related]
18. Sensitization of cancer cells treated with cytotoxic drugs to fas-mediated cytotoxicity. Micheau O; Solary E; Hammann A; Martin F; Dimanche-Boitrel MT J Natl Cancer Inst; 1997 Jun; 89(11):783-9. PubMed ID: 9182976 [TBL] [Abstract][Full Text] [Related]